Navigation Links
Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections
Date:7/27/2009

e(TM) both in the United States and international markets while Unomedical has exclusive manufacturing rights.

"With the i-port Advance(TM) we can offer more people with diabetes access to a user-friendly and safe device designed for safe delivery of insulin. The dedication of Patton Medical Devices towards promoting injection port therapy combined with our expertise in designing and manufacturing high quality insulin delivery devices is a perfect match for bringing this new and innovative product to the market." John M Lindskog, Vice President & General Manager, Unomedical Infusion Devices

Device demonstrations of the i-port Advance(TM) will be unveiled at the annual American Association of Diabetes Educators Conference in Atlanta, Georgia August 4-8, 2009. Both companies are working together to have the i-port Advance(TM) commercially available in the United States and other select countries by April 2010.

About Patton Medical Devices

Headquartered in Austin, Texas, Patton Medical Devices is the manufacturer of the i-port(R) Injection Port. For people taking injections who want to minimize the intrusion of injections on daily life, the i-port(R) is the only product of its kind conceived by a person with diabetes that offers a simple, convenient way to eliminate the need to puncture the skin with each dose of medication. The i-port(R) lets patients focus on living their lives instead of the challenges associated with the next shot. i-port(R) is a registered trademark and i-port Advance(TM) is a trademark of Patton Medical Devices. For more information about Patton Medical Devices, its products and services, visit www.i-port.com or www.pattonmd.com.'/>"/>

SOURCE Patton Medical Devices
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
2. Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting
3. Symphony Medical Changes Name to CardioPolymers, Inc.
4. Environmental Tectonics Corporation Announces Promotion of Don R. Webber to VP of Sales for their BioMedical Division
5. Regado Biosciences Expands Medical Advisory Board
6. BioMS Medical announces second quarter 2009 results
7. NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
8. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
9. Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test
10. Powerful Image Registration and Recognition Software Unveiled for Medical, Satellite, and Defense Imaging Industries
11. IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... China, Dec. 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... (Nasdaq: CSKI ), a,leading fully integrated pharmaceutical ... Republic of China ("PRC"), today,announced that the Company ... the 2009,Edition of the National Basic Medical Insurance, ... The 30 medicines treat ...
(Date:12/15/2009)... Microscopy (AFM) have been developed and are opening up a ... The NeedleProbes’ cylindrical geometry enables researchers to measure surface ... all in a single force distance curve. , ... ... diameter NeedleProbes are enabling unique measurements at the ...
(Date:12/15/2009)... 15 On January 20th, 2010, the ... Medical Publication Professionals (ISMPP) will be held at ... More than 100 attendees are expected at this ... professionals, editors, publishers, medical writers and medical agencies ... and the impact of guidelines and regulations such ...
(Date:12/14/2009)... 14 Array BioPharma Inc. (Nasdaq: ... today announced that they entered into an agreement ... glucokinase activator program, including ARRY-403, currently being tested ... with Type 2 diabetes. ,, Under ... an upfront payment of $60 million and additional ...
Breaking Biology Technology:China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... press conference,Orange Romania & Medic4all launched Medic4you, the ... is the fundamental value of the quality of ... together the Medic4you service in,Romania," stated Christos Phocas, ... Medic4you is a telemedicine service based on ...
... today announced that its Analyst Day in New York ... webcast live on the investor relations section of,its website ... review the company,s business,strategy, marketing plan and research and ... 5, 2008 beginning at,approximately 12:30 p.m. EST and ending ...
... Research Effort Includes Development and Application of PulmoSmartChip - ... Custom Molecular Phenotyping Assay for Lung Disease, ... Board: WGBS), a leading developer of state-of-the-art,gene expression, genotyping, ... the National Institutes of Health (NIH) has awarded a,team ...
Other Biology Technology:Orange and Medic4all Launched the World's First Cellular Tele-Health Service 2Cephalon, Inc. to Webcast Analyst Day 2Cephalon, Inc. to Webcast Analyst Day 3NIH Awards Approximately $3M Grant for Research Involving WaferGen's SmartChip(TM) Real-Time PCR System at the University of Pittsburgh 2NIH Awards Approximately $3M Grant for Research Involving WaferGen's SmartChip(TM) Real-Time PCR System at the University of Pittsburgh 3NIH Awards Approximately $3M Grant for Research Involving WaferGen's SmartChip(TM) Real-Time PCR System at the University of Pittsburgh 4NIH Awards Approximately $3M Grant for Research Involving WaferGen's SmartChip(TM) Real-Time PCR System at the University of Pittsburgh 5NIH Awards Approximately $3M Grant for Research Involving WaferGen's SmartChip(TM) Real-Time PCR System at the University of Pittsburgh 6
(Date:12/14/2009)... be transmitted by sneezing, touching, or for Tasmanian ... habit that may have driven the dinosaurs to extinction ... Upcroft, a member of f1000 Biology, highlights the ,paleobiological ... PLoS One. This led them to deduce that a ... bones seen in many tyrannosaurid fossils. , The parasite,s ...
(Date:12/14/2009)... ON, December 10, 2009If you are spending the holidays ... wondering whether you would be better off with another ... , A research team from McMaster University and ... among cichlids, a species that lives in groups, members ... The results appear in the current issue of ...
(Date:12/14/2009)... Convention on Climate Change taking place in Copenhagen, ... Trend, event on Sunday evening to provide a ... of the new ,Environmental Atlas of Europe,. , ... of the European Environment Agency (EEA), the UN ... of short films showing the significance of environmental ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 1Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 2Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 3Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 4AssureRx Adds New CEO 12542 1AssureRx Adds New CEO 12542 2RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 48282 1RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 48282 2RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 48282 3
... to buy a bag of carbon nanotubesin quantities from ... = approximately 220 pounds)? With a credit card and ... doing enough to ensure the safety of these materials ... products currently on the market? , The ...
... infections, may be a strong weapon in the ... to an article in the November issue of ... seen as exotic diseases, but this is changing ... infections are a major problem for the immunocompromised, ...
... a controversial hypothesis of biodiversity and species abundance is the ... November 2007 issue of the journal Nature. The authors ... the world,s most vulnerable ecosystems -- tropical forests and coral ... so-called "neutral theory of biodiversity." "We,re helping to refine ...
Other Biology News:US government delays nanotechnology safety measures 2Gamma interferon could aid fight against fungal infections 2Why do so many species live in tropical forests and coral reefs? 2Why do so many species live in tropical forests and coral reefs? 3Why do so many species live in tropical forests and coral reefs? 4